Stages I-II/ Anal Cancer News


Recent Stages I-II/ Anal Cancer News

Investigational Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers (December 1, 2015)

COLUMBUS, Ohio – New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known... Continue Reading

Radiation After Lumpectomy Improves Outcomes Among Elderly with Triple-Negative Breast Cancer (November 30, 2015)

The addition of radiation therapy following a lumpectomy appears to significantly improve outcomes among elderly women with triple-negative breast cancer. These results were recently presented at the 2015... Continue Reading

FDA Approves Opdivo for Renal Cell Carcinoma (November 25, 2015)

The FDA granted approval to nivolumab (Opdivo) for patients with renal cell carcinoma. Opdivo, a PD-1 inhibitor, was previously approved for the treatment of melanoma whose tumors express the BRAF V600... Continue Reading

Do You Have Heartburn or GERD? (November 24, 2015)

GERD Awareness Week is November 22 – 28, 2015 and takes place each year during the week of Thanksgiving.   GERD is a common disorder that occurs when the contents of the stomach repeatedly flow back... Continue Reading

Long-Term Survival Benefit Demonstrated with RINTEGA® in Recurrent Glioblastoma (November 24, 2015)

Mature survival data from a randomized, double-blind Phase 2 clinical study evaluating RINTEGA® (rindopepimut) in patients with EGFRvIII-positive, recurrent glioblastoma (GBM) were recently presented... Continue Reading

Ninlaro® Approved for Multiple Myeloma (November 23, 2015)

The United States Food and Drug Administration (FDA) has granted approval to Ninlaro® (ixazomib) for the treatment of multiple myeloma. This marks the third drug approved this year for the treatment of... Continue Reading

Novel Precision Medicine Tagrisso Approved for Treatment of Lung Cancer (November 19, 2015)

The United States Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for the treatment of lung cancer with the epidermal growth factor receptor (EGFR) T790M mutation. The indication... Continue Reading

Zydelig® Combined with Treanda and Rituxan Appears Promising in Treatment of Chronic Lymphocytic Leukemia (November 18, 2015)

Following the recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc today announced that its Phase 3 clinical study evaluating Zydelig® (idelalisib) added to standard... Continue Reading

November is National Pancreatic Cancer Awareness Month (November 17, 2015)

Copyright © 2015 CancerConnect. All Rights Reserved. Read More →

FDA Approves Darzalex Providing a New Treatment for Patients with Multiple Myeloma (November 17, 2015)

Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma. Darzalex is the first monoclonal antibody approved for treating... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS